Alexander G. Khandji

New York Hospital Queens — United States

Medicine · Health Sciences

27h-index2.2kcitations72works1.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pituitary Gland Disorders and Treatments(13), Glioma Diagnosis and Treatment(12), Growth Hormone and Insulin-like Growth Factors(11), Vascular Malformations Diagnosis and Treatment(8), Intracranial Aneurysms: Treatment and Complications(7)

Publications72 total

Surgical treatment of myxopapillary ependymoma: an institutional case series of 56 patients
Journal of Neurosurgery Spine·2026
Prospective Observational Study of 118 Clinically Nonfunctioning Pituitary Adenomas
Endocrine Practice·2025
Temporal Trends in <scp>CT</scp> Angiography for Acute Stroke Symptoms
Academic Emergency Medicine·2025Open Access
Sweet Syndrome in the Central Nervous System: A Case of Orbital Inflammation, Sixth Nerve Palsy, and Pachymeningitis
Journal of Neuro-Ophthalmology·2024
Prospective, Longitudinal Study of Cancer Predictors and Rates in a New York City Cohort of 598 Patients With Acromegaly
The Journal of Clinical Endocrinology & Metabolism·2024· 6 citedOpen Access
Ropinirole for the Treatment of Hyperprolactinemia: A Dose-Escalation Study of Efficacy and Tolerability
The Journal of Clinical Endocrinology & Metabolism·2023· 1 citedOpen Access
468 Relationship Between Tumor Location and Quality and Extent of Resection in the Surgical Treatment of Myxopapillary Ependymoma
Neurosurgery·2023
COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital
Brain·2021· 387 citedOpen Access
COVID-19 Neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital
2021· 50 citedOpen Access
Gonadotroph tumours with a low SF‐1 labelling index are more likely to recur and are associated with enrichment of the PI3K‐AKT pathway
Neuropathology and Applied Neurobiology·2020· 13 citedOpen Access
Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly
Pituitary·2020· 22 citedOpen Access
MON-282 Treatment of Hyperprolactinemia with Ropinirole: An Open-Label Dose Escalation Study
Journal of the Endocrine Society·2020· 2 citedOpen Access
MON-307 Prospective, Longitudinal Study of Glucose-Suppressed GH Levels in 87 Acromegaly Patients with IGF-1 Normalization After Surgical Therapy: Prognostic Value of Nadir GH Levels for Long-Term Remission or Recurrence
Journal of the Endocrine Society·2020Open Access
MON-309 Prevalence of Silent Corticotroph Adenomas in a Large Cohort of Nonfunctioning Pituitary Adenomas: Plasma Proopiomelanocortin(POMC) Levels and Response to Pasireotide LAR
Journal of the Endocrine Society·2020· 1 citedOpen Access
Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study
Journal of the Endocrine Society·2020· 35 citedOpen Access
Exploring mTOR inhibition as treatment for mitochondrial disease
Annals of Clinical and Translational Neurology·2019· 49 citedOpen Access
Exploring mTOR Inhibition as Treatment for Mitochondrial Disease (P4.6-060)
Neurology·2019
Pitfall in the Diagnosis of Diabetes Insipidus and Pregnancy
Case Reports in Obstetrics and Gynecology·2017· 5 citedOpen Access
Isoflurane Use in the Treatment of Super-Refractory Status Epilepticus is Associated with Hippocampal Changes on MRI
Neurocritical Care·2016· 17 cited
Intrathecal Injections in Children With Spinal Muscular Atrophy
Journal of Child Neurology·2016· 197 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Pamela U. Freda(9), Jeffrey N. Bruce(8), E. Sander Connolly(7), Sharon L. Wardlaw(7), Jan Claassen(5), Kurenai Tanji(5), Ricardo J. Komotar(5), Phyllis L. Faust(4), Richard A. Hickman(4), J Mocco(4), Kalmon D. Post(4), Peter Canoll(3), Paul C. McCormick(3), Neeraj Badjatia(3), Stephan A. Mayer(3), Zhezhen Jin(3), Marc L. Otten(3), Kiran T. Thakur(2), Emily Happy Miller(2), Michael Glendinning(2)